よむ、つかう、まなぶ。
【参考資料２－３】抗微生物薬適正使用の手引き 第四版（案）薬剤耐性菌感染症の抗菌薬適正使用編 (59 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_64503.html |
| 出典情報 | 厚生科学審議会 感染症部会（第99回 10／21）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
抗微生物薬適正使用の手引き
第四版
薬剤耐性菌感染症の抗菌薬適正使用編
1
2
3
214. Igarashi Y, et al. Oral vancomycin versus metronidazole for the treatment of
Clostridioides difficile infection: Meta-analysis of randomized controlled trials. J Infect
Chemother. 2018. 24(11):907-914.
4
5
6
215. Tashiro S, et al. Oral fidaxomicin versus vancomycin for the treatment of Clostridioides
difficile infection: A systematic review and meta-analysis of randomized controlled trials.
J Infect Chemother. 2022. 28(11):1536-1545.
7
8
216. Probiotics revisited. No authors listed. JAMA. 2014. 312(17):1796.
https://pubmed.ncbi.nlm.nih.gov/25369492/
9
10
217. Denning DW. Global incidence and mortality of severe fungal disease. Lancet Infect Dis
2024;24:e428-38.
11
12
218. Clancy CJ, et al. Diagnosing Invasive Candidiasis. J Clin Microbiol. 2018. 56(5):e0190917.
13
14
219. Bassetti M, et al. Bench-to-bedside review: therapeutic management of invasive
candidiasis in the intensive care unit. Crit Care. 2010. 14(6):244.
15
220. Kullberg BJ, et al. Invasive Candidiasis. N Engl J Med. 2015. 373(15):1445-1456.
16
17
18
221. Alexander BD, et al. Increasing echinocandin resistance in Candida glabrata: clinical
failure correlates with presence of FKS mutations and elevated minimum inhibitory
concentrations. Clin Infect Dis. 2013. 56:1724-32.
19
20
222. Pham CD, et al. Role of FKS Mutations in Candida glabrata: MIC values, echinocandin
resistance, and multidrug resistance. Antimicrob Agents Chemother 2014. 58:4690-6.
21
22
223. Coste AT, et al. Emerging echinocandin-resistant Candida albicans and glabrata in
Switzerland. Infection. 2020. 48:761-6.
23
24
224. Khalifa HO, et al. Genetic Basis of Azole and Echinocandin Resistance in Clinical
Candida glabrata in Japan. Antimicrob Agents Chemother. 2020. 64:e00783-20
25
26
225. Kim HY, et al. Candida auris-a systematic review to inform the world health organization
fungal priority pathogens list. Med Mycol. 2024. 62:myae04.
27
28
226. Long B, et al. Candida auris: A focused review for emergency clinicians. Am J Emerg
Med. 2024. 84:162-7.
29
30
227. Jeffery-Smith A, et al. Candida auris: a Review of the Literature. Clin Microbiol Rev.
2017. 31(1):e00029-17.
31
32
228. Karageorgopoulos DE, et al. beta-D-glucan assay for the diagnosis of invasive fungal
infections: a meta-analysis. Clin Infect Dis. 2011. 52(6):750-770.
33
34
35
229. Onishi A, et al. Diagnostic accuracy of serum 1,3-beta-D-glucan for pneumocystis
jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review
and meta-analysis. J Clin Microbiol. 2012. 50(1):7-15.
36
37
38
39
230. 松田宇翔. 全自動遺伝子解析装置 FilmArray® システム 製品概要および保険適用につい
ての情報提供 日本医療検査科学会 第 52 回大会 第 3 回微生物検査・感染症技術セミ
ナーhttps://jcls.or.jp/wpcontent/uploads/2020/09/ea40865330cdbfb70003a70e73c815f3.pdf
40
231. 吉田耕一郎, 他. 深在性真菌症診断とβ-D-グルカン値測定. 日集中医誌. 2010.17:1.
41
42
43
232. Hsu AJ, et al. Challenges with utilizing the 1,3-Beta-d-glucan and galactomannan assays
to diagnose invasive mold infections in immunocompromised children. J Clin Microbiol.
2021. 59:e0327620.
59
第四版
薬剤耐性菌感染症の抗菌薬適正使用編
1
2
3
214. Igarashi Y, et al. Oral vancomycin versus metronidazole for the treatment of
Clostridioides difficile infection: Meta-analysis of randomized controlled trials. J Infect
Chemother. 2018. 24(11):907-914.
4
5
6
215. Tashiro S, et al. Oral fidaxomicin versus vancomycin for the treatment of Clostridioides
difficile infection: A systematic review and meta-analysis of randomized controlled trials.
J Infect Chemother. 2022. 28(11):1536-1545.
7
8
216. Probiotics revisited. No authors listed. JAMA. 2014. 312(17):1796.
https://pubmed.ncbi.nlm.nih.gov/25369492/
9
10
217. Denning DW. Global incidence and mortality of severe fungal disease. Lancet Infect Dis
2024;24:e428-38.
11
12
218. Clancy CJ, et al. Diagnosing Invasive Candidiasis. J Clin Microbiol. 2018. 56(5):e0190917.
13
14
219. Bassetti M, et al. Bench-to-bedside review: therapeutic management of invasive
candidiasis in the intensive care unit. Crit Care. 2010. 14(6):244.
15
220. Kullberg BJ, et al. Invasive Candidiasis. N Engl J Med. 2015. 373(15):1445-1456.
16
17
18
221. Alexander BD, et al. Increasing echinocandin resistance in Candida glabrata: clinical
failure correlates with presence of FKS mutations and elevated minimum inhibitory
concentrations. Clin Infect Dis. 2013. 56:1724-32.
19
20
222. Pham CD, et al. Role of FKS Mutations in Candida glabrata: MIC values, echinocandin
resistance, and multidrug resistance. Antimicrob Agents Chemother 2014. 58:4690-6.
21
22
223. Coste AT, et al. Emerging echinocandin-resistant Candida albicans and glabrata in
Switzerland. Infection. 2020. 48:761-6.
23
24
224. Khalifa HO, et al. Genetic Basis of Azole and Echinocandin Resistance in Clinical
Candida glabrata in Japan. Antimicrob Agents Chemother. 2020. 64:e00783-20
25
26
225. Kim HY, et al. Candida auris-a systematic review to inform the world health organization
fungal priority pathogens list. Med Mycol. 2024. 62:myae04.
27
28
226. Long B, et al. Candida auris: A focused review for emergency clinicians. Am J Emerg
Med. 2024. 84:162-7.
29
30
227. Jeffery-Smith A, et al. Candida auris: a Review of the Literature. Clin Microbiol Rev.
2017. 31(1):e00029-17.
31
32
228. Karageorgopoulos DE, et al. beta-D-glucan assay for the diagnosis of invasive fungal
infections: a meta-analysis. Clin Infect Dis. 2011. 52(6):750-770.
33
34
35
229. Onishi A, et al. Diagnostic accuracy of serum 1,3-beta-D-glucan for pneumocystis
jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review
and meta-analysis. J Clin Microbiol. 2012. 50(1):7-15.
36
37
38
39
230. 松田宇翔. 全自動遺伝子解析装置 FilmArray® システム 製品概要および保険適用につい
ての情報提供 日本医療検査科学会 第 52 回大会 第 3 回微生物検査・感染症技術セミ
ナーhttps://jcls.or.jp/wpcontent/uploads/2020/09/ea40865330cdbfb70003a70e73c815f3.pdf
40
231. 吉田耕一郎, 他. 深在性真菌症診断とβ-D-グルカン値測定. 日集中医誌. 2010.17:1.
41
42
43
232. Hsu AJ, et al. Challenges with utilizing the 1,3-Beta-d-glucan and galactomannan assays
to diagnose invasive mold infections in immunocompromised children. J Clin Microbiol.
2021. 59:e0327620.
59